A Post-Marketing Study of the Immunogenicity of Somatropin (Ribosomal Deoxyribo Nucleic Acid [rDNA] Origin) Injection (Nutropin AQ®) in Children With Growth Hormone Deficiency
Clinical trial NCT02311894 · COMPLETED
Trial details
- NCT number
- NCT02311894
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-31
- Primary completion
- 2017-11-08
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.